32 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
3 Aug 21
Rhythm Pharmaceuticals Reports Second Quarter 2021 Financial Results
7:05am
announced an exclusive distribution agreement with Medison Pharma, a leading commercial partner for highly innovative therapies in international markets
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
2 Aug 22
Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results and Business Update
7:02am
to innovative therapies in France prior to regulatory approval when a positive benefit/risk ratio is recognized and when no other therapeutic alternatives
424B4
RYTM
Rhythm Pharmaceuticals Inc.
21 Jun 18
Prospectus supplement with pricing info
4:55pm
obesity to develop innovative therapies that we believe have the potential for compelling efficacy. Setmelanotide's unique mechanism of action … and in-licensed innovative pharmaceutical products, and we have subsequently expanded our senior management team to further broaden our team's experience
DRS
RYTM
Rhythm Pharmaceuticals Inc.
11 Jun 18
Draft registration statement
12:00am
a different approach to obesity drug development
by leveraging new understanding of the genetic causes of severe obesity to develop innovative … and in-licensed innovative pharmaceutical products, and we have subsequently expanded our senior management team to further broaden our team's experience
10-K
1t6uh1bahf4kfdve
12 Mar 18
Annual report
12:00am